Transamerica Financial Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-17
Closed -$1.73K 1984
2025
Q4
$1.73K Buy
17
+1
+6% +$80 ﹤0.01% 1154
2025
Q3
$875 Buy
+16
New +$799 ﹤0.01% 1191
2015
Q4
Sell
-100
Closed -$2K 835
2015
Q3
$2K Hold
100
﹤0.01% 697
2015
Q2
$3K Hold
100
﹤0.01% 736
2015
Q1
$3K Hold
100
﹤0.01% 736
2014
Q4
$3K Hold
100
﹤0.01% 584
2014
Q3
$2K Buy
+100
New +$1.83K ﹤0.01% 573

Other funds holding EXAS

Transamerica Financial Advisors's EXAS Position: Q1 2026 in Review

Transamerica Financial Advisors sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 17 shares — an estimated $1.73K sold.

Transamerica Financial Advisors first reported a position in EXAS in Q3 2014 and held it in 7 quarters. The position peaked at $3K in Q2 2015. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Transamerica Financial Advisors reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Transamerica Financial Advisors sold 17 Exact Sciences shares in Q1 2026, an estimated $1.73K.
  • Transamerica Financial Advisors first reported a position in Exact Sciences in Q3 2014 and held it in 7 quarters.
  • Transamerica Financial Advisors's Exact Sciences position peaked at $3K in Q2 2015.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Transamerica Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.